Stockscreener 앱 받기
0.4993
15.34%
-0.0905
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Canada
Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock - TradingView
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com India
Medical Journal Article Highlights Technology’s Potential to Detect Heart Attack Risk at Home - Medical Product Outsourcing
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... - Investing.com Canada
Heartbeam earnings missed by $1.01, revenue fell short of estimates - Investing.com Canada
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss By Investing.com - Investing.com Australia
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss - Investing.com
Why is Heartbeam stock sliding today? By Investing.com - Investing.com India
Earnings call transcript: HeartBeam posts wider Q2 2026 loss, stock slips after hours - Investing.com
BEAT: FDA pre-submission for heart attack detection and commercial rollout drive growth, with costs down - TradingView
HeartBeam Q2 Results: Net loss narrows to $5M, cash burn down 7% - scanx.trade
BEAT: FDA pre-submission completed, commercial rollout expands, and cash runway extended into 2027 - TradingView
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Why is Heartbeam stock sliding today? - Investing.com
HeartBeam, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-08-13 - Seeking Alpha
HeartBeam, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
HeartBeam (BEAT): Strome group details 6.8% ownership and July–August share sales - Stock Titan
HeartBeam posts wider Q2 loss than expected, shares inch lower By Investing.com - Investing.com South Africa
HeartBeam Q2 2026 results: Cash-burn outlook improves as net loss holds near $5 million - TradingKey
HeartBeam (NASDAQ: BEAT) details Q2 loss, $11.5M equity raise and Nasdaq risk - Stock Titan
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HeartBeam Reports Second Quarter 2026 Results - Business Wire
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Lo - GuruFocus
Heartbeam Inc (BEAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Earnings Preview: HeartBeam to Report Financial Results Post-market on August 13 - Moomoo
HeartBeam, Inc. (BEATW) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enterprise value to EBIT forward of Heartbeam, Inc. – NASDAQ:BEATW - TradingView
Price to sales forward of Heartbeam, Inc. – NASDAQ:BEATW - TradingView
Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
$HeartBeam (BEAT.US)$ - Moomoo
Heartbeam Inc (BEAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartbeam Inc (BEAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heartbeam Inc (BEAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Heartbeam Inc (BEAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BEAT|Heartbeam Inc|Price:0.584|Chg%:+0.012 - TradingKey
Heartbeam Inc (BEAT) Institutional Confidence - TradingKey
BEAT|Heartbeam Inc|Price:0.501|Chg%:-0.017 - TradingKey
Heartbeam Inc (BEAT) Balance Sheet - TradingKey
BEAT|Heartbeam Inc|Price:0.512| - TradingKey
Heartbeam Inc (BEAT) Income Statement - TradingKey
Heartbeam Inc (BEAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartbeam Inc. (BEAT) Q1 2026 Earnings: EPS Beats Estimates but Stock Declines Amid Revenue Uncertainty - dars.gov.et
Heartbeam Inc (BEAT) Cash Flow - TradingKey
Form 4 Heartbeam Inc For: 25 July By Investing.com - Investing.com South Africa
HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan
HeartBeam, Inc. (BEAT) awards 167,760 RSUs to CFO as 2025 bonus - Stock Titan
HeartBeam, Inc. (BEAT) Grants 2,800,000 PRSUs and RSUs to President - Stock Titan
Heartbeam, Inc. (BEAT) Q3 2022 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam, Inc. (BEAT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Heartbeam Inc. Warrant (BEATW) Surges 16.85% Amid Thin TradingIndex Put Call - dars.gov.et
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now - The Globe and Mail
Stock Ratings | HC Wainwright lowered its price target for NervGen Pharma (NGEN) to $15, with a potential upside of 762.07%; KeyBanc raised its price target for Nvidia (NVDA) to $330 - Sahm
BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00 - GuruFocus
HeartBeam receives patent for multi-modal cardiac sensing device - Investing.com UK
Maxim Group Initiates HeartBeam(BEAT.US) With Buy Rating, Announces Target Price $2 - Moomoo
HeartBeam receives patent for multi-modal cardiac sensing device By Investing.com - Investing.com Nigeria
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device - Business Wire
1.10%
6.73%
자본화:
|
볼륨(24시간):